These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27603)

  • 1. Multiple-scored tablets. Weight and content uniformity of subdivisions and distribution of active constituent within and between tablets.
    Walker J; Abdulsalam A; Theobald AE; Subrahmanyam R; Verma SK
    J Pharm Pharmacol; 1978 Jul; 30(7):401-6. PubMed ID: 27603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry.
    Ciavarella AB; Khan MA; Gupta A; Faustino PJ
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):523-532. PubMed ID: 27974592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.
    Hill SW; Varker AS; Karlage K; Myrdal PB
    J Manag Care Pharm; 2009 Apr; 15(3):253-61. PubMed ID: 19326956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tablet splitting: is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting.
    Helmy SA
    J Manag Care Spec Pharm; 2015 Jan; 21(1):76-86. PubMed ID: 25562775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of content and uniformity of content of tablets prepared with a low concentration in active ingredient.
    Gayot A; Blouet E; Leterme P; Traisnel M
    Boll Chim Farm; 1988; 127(9-10):218-20. PubMed ID: 3248160
    [No Abstract]   [Full Text] [Related]  

  • 6. Liquid chromatographic determination of levodopa and levodopa-carbidopa in solid dosage forms: collaborative study.
    Ting S
    J Assoc Off Anal Chem; 1987; 70(6):987-90. PubMed ID: 3436915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Content uniformity of potent drugs in tablets.
    Orr NA; Sallam EA
    J Pharm Pharmacol; 1978 Dec; 30(12):741-7. PubMed ID: 32236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of weight uniformity, content uniformity and 30-day stability in halves and quarters of routinely prescribed cardiovascular medications.
    Margiocco ML; Warren J; Borgarelli M; Kukanich B
    J Vet Cardiol; 2009 Jun; 11(1):31-9. PubMed ID: 19477704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the distributional homogeneity on chlorpheniramine maleate tablets using NIR-CI.
    Ma L; Zhou L; Xu M; Huang X; Zhang Q; Dai S; Qiao Y; Wu Z
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Nov; 204():783-790. PubMed ID: 30096731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spectrophotometric determination of sulfapyridazine and sulfadimethoxine in tablets].
    Chichiro VE; Semeĭkina LA
    Farmatsiia; 1970; 19(4):43-5. PubMed ID: 5488019
    [No Abstract]   [Full Text] [Related]  

  • 11. [Content uniformity of warfarin-containing mixtures and tablets].
    Franc A; Muselík J; Máslová R; Hadrabová J
    Ceska Slov Farm; 2013 Aug; 62(4):177-81. PubMed ID: 24047147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical equivalent studies of some commercially available brands of Loratadine hydrochloride tablets.
    Adetunji OA; Adigun NF; Odeniyi MA
    Afr J Med Med Sci; 2015 Sep; 44(3):269-76. PubMed ID: 27280240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of marketed antimalarial chloroquine phosphate tablets.
    Patel AK; Prajapati BG; Moria RS; Patel CN
    J Vector Borne Dis; 2005 Dec; 42(4):147-50. PubMed ID: 16457384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uniformity of distribution of cyanocobalamin in tablet formulations.
    Nessel RJ; Apelian HM; Blodinger J
    J Pharm Sci; 1970 Feb; 59(2):254-7. PubMed ID: 5411350
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro quality evaluation of leading brands of ciprofloxacin tablets available in Bangladesh.
    Uddin MS; Mamun AA; Hossain MS; Asaduzzaman M; Sarwar MS; Rashid M; Herrera-Calderon O
    BMC Res Notes; 2017 May; 10(1):185. PubMed ID: 28558832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor analysis in optimization of formulation of high content uniformity tablets containing low dose active substance.
    Lukášová I; Muselík J; Franc A; Goněc R; Mika F; Vetchý D
    Eur J Pharm Sci; 2017 Nov; 109():541-547. PubMed ID: 28912027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is propranolol compounding from tablet safe for pediatric use? Results from an experimental test.
    Casiraghi A; Musazzi UM; Franceschini I; Berti I; Paragò V; Cardosi L; Minghetti P
    Minerva Pediatr; 2014 Oct; 66(5):355-62. PubMed ID: 25253183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of mean potency and content uniformity of tablets: a new approach.
    Comer JP; Breunig HL; Broadlick DE; Sampson CB
    J Pharm Sci; 1970 Feb; 59(2):210-4. PubMed ID: 5411343
    [No Abstract]   [Full Text] [Related]  

  • 19. Strategic development of a multivariate calibration model for the uniformity testing of tablets by transmission NIR analysis.
    Sasakura D; Nakayama K; Sakamoto T; Chikuma T
    Pharmazie; 2015 May; 70(5):289-95. PubMed ID: 26062295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of content uniformity of tablets with a low content of the active ingredient with a narrow therapeutic index].
    Muselík J; Franc A
    Ceska Slov Farm; 2012 Dec; 61(6):271-5. PubMed ID: 23387856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.